This study is testing whether a daily low-dose aspirin pill can help prevent colorectal cancer from returning after surgery. It focuses on patients whose tumors have specific genetic changes in the PI3K pathway. Participants take either aspirin or a placebo pill daily for three y…
Phase: PHASE3 • Sponsor: Anna Martling • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC